{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:37:42Z","timestamp":1768347462099,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","funder":[{"DOI":"10.13039\/100009210","name":"FDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Rapidly evolving RNA viruses, such as human norovirus, generate extraordinary sequence diversity, posing a significant challenge to vaccine design. This diversity, coupled with short-lasting natural immunity, leads to reinfection throughout one's lifetime. How reexposure shapes humoral immunity to future norovirus strains remains incompletely understood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We profiled the antibody responses following 2 community gastroenteritis outbreaks with GII.2 and GII.6 noroviruses in 1971. Using diverse virus-like particles (VLPs), enzyme-linked immunosorbent assay (ELISA), and carbohydrate-blocking assays (surrogate for neutralization), we examined the antibody response at acute and convalescent timepoints following GII.6 infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Convalescent sera displayed strong homologous blocking, demonstrating a 5-fold increase in GII.6 carbohydrate blockade over acute samples, and broad blocking of diverse archival and modern GII.6 noroviruses. Convalescent sera displayed limited carbohydrate blocking of heterotypic VLPs, despite high ELISA binding titers. Select individuals developed broad cross-genotype blockade, but this response was established before the second outbreak. Finally, we applied a novel competitive carbohydrate-blocking assay to demonstrate the epitope specificity and discrete compartments of the neutralizing response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our data show that infection generates narrow, focused immunity directed toward the infecting genotype. We did detect broad cross-blocking in specific individuals, but these responses could be attributed to diverse, genotype-specific antibodies predating GII.6 infection.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae085","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T23:10:05Z","timestamp":1708557005000},"source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Archival Sera From Norovirus-Infected Individuals Demonstrates That Cross-Blocking of Emerging Viruses Is Genotype-Specific"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-4098","authenticated-orcid":false,"given":"Kelsey A","family":"Pilewski","sequence":"first","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-4678","authenticated-orcid":false,"given":"Lauren A","family":"Ford-Siltz","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-9355","authenticated-orcid":false,"given":"Kentaro","family":"Tohma","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5886-7377","authenticated-orcid":false,"given":"Joseph A","family":"Kendra","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1148-0008","authenticated-orcid":false,"given":"Michael","family":"Landivar","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-4740","authenticated-orcid":false,"given":"Gabriel I","family":"Parra","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"2024031919121902300_jiae085-B1","doi-asserted-by":"crossref","first-page":"e1001999","DOI":"10.1371\/journal.pmed.1001999","article-title":"The vast and varied global burden of norovirus: prospects for prevention and control","volume":"13","author":"Lopman","year":"2016","journal-title":"PLoS Med"},{"key":"2024031919121902300_jiae085-B2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa438","article-title":"Burden of norovirus in the United States, as estimated based on administrative data: updates for medically attended illness and mortality, 2001\u20132015","volume":"73","author":"Burke","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024031919121902300_jiae085-B3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J Gen Virol"},{"key":"2024031919121902300_jiae085-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1900994","article-title":"Understanding the relationship between norovirus diversity and immunity","volume":"13","author":"Ford-Siltz","year":"2021","journal-title":"Gut Microbes"},{"key":"2024031919121902300_jiae085-B5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.clinthera.2017.07.002","article-title":"Prospects and challenges in the development of a norovirus vaccine","volume":"39","author":"Cortes-Penfield","year":"2017","journal-title":"Clin Ther"},{"key":"2024031919121902300_jiae085-B6","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/infdis\/jiaa292","article-title":"The clinical and economic burden of norovirus gastroenteritis in the United States","volume":"222","author":"Bartsch","year":"2020","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/cid\/cit763","article-title":"Multiple norovirus infections in a birth cohort in a Peruvian periurban community","volume":"58","author":"Saito","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024031919121902300_jiae085-B8","doi-asserted-by":"crossref","first-page":"e1006136","DOI":"10.1371\/journal.ppat.1006136","article-title":"Static and evolving norovirus genotypes: implications for epidemiology and immunity","volume":"13","author":"Parra","year":"2017","journal-title":"PLoS Pathog"},{"key":"2024031919121902300_jiae085-B9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/cid\/ciaa019","article-title":"Homotypic and heterotypic protection and risk of reinfection following natural norovirus infection in a highly endemic setting","volume":"72","author":"Chhabra","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024031919121902300_jiae085-B10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1908.130472","article-title":"Duration of immunity to norovirus gastroenteritis","volume":"19","author":"Simmons","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2024031919121902300_jiae085-B11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/jvi.37.3.994-999.1981","article-title":"Proteins of Norwalk virus","volume":"37","author":"Greenberg","year":"1981","journal-title":"J Virol"},{"key":"2024031919121902300_jiae085-B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/viro.1993.1345","article-title":"Sequence and genomic organization of Norwalk virus","volume":"195","author":"Jiang","year":"1993","journal-title":"Virology"},{"key":"2024031919121902300_jiae085-B13","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.0803275105","article-title":"Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus","volume":"105","author":"Choi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024031919121902300_jiae085-B14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"2024031919121902300_jiae085-B15","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/jvi.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"2024031919121902300_jiae085-B16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/jcm.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2024031919121902300_jiae085-B17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/v11070638","article-title":"Human norovirus cultivation in nontransformed stem cell-derived human intestinal enteroid cultures: success and challenges","volume":"11","author":"Estes","year":"2019","journal-title":"Viruses"},{"key":"2024031919121902300_jiae085-B18","doi-asserted-by":"crossref","first-page":"e63485","DOI":"10.1371\/journal.pone.0063485","article-title":"Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models","volume":"8","author":"Papafragkou","year":"2013","journal-title":"PLoS One"},{"key":"2024031919121902300_jiae085-B19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/427779","article-title":"Association of histo-blood group antigens and susceptibility to norovirus infections","volume":"191","author":"Rockx","year":"2005","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B20","doi-asserted-by":"crossref","first-page":"e00251-20","DOI":"10.1128\/mBio.00251-20","article-title":"Genetic manipulation of human intestinal enteroids demonstrates the necessity of a functional fucosyltransferase 2 gene for secretor-dependent human norovirus infection","volume":"11","author":"Haga","year":"2020","journal-title":"mBio"},{"key":"2024031919121902300_jiae085-B21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tim.2005.04.004","article-title":"Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle","volume":"13","author":"Tan","year":"2005","journal-title":"Trends Microbiol"},{"key":"2024031919121902300_jiae085-B22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"2024031919121902300_jiae085-B24","first-page":"739","article-title":"Comparison of microneutralization and histo-blood group antigen-blocking assays for functional norovirus antibody detection","volume":"221","author":"Atmar","year":"2020","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/infdis\/jiaa116","article-title":"Genotype-specific neutralization of norovirus is mediated by antibodies against the protruding domain of the major capsid protein","volume":"225","author":"Ford-Siltz","year":"2022","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B26","doi-asserted-by":"crossref","first-page":"110689","DOI":"10.1016\/j.celrep.2022.110689","article-title":"Dynamic immunodominance hierarchy of neutralizing antibody responses to evolving GII.4 noroviruses","volume":"39","author":"Tohma","year":"2022","journal-title":"Cell Rep"},{"key":"2024031919121902300_jiae085-B27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad401","article-title":"A bivalent human norovirus vaccine induces homotypic and heterotypic neutralizing antibodies [manuscript published online ahead of print 2 October 2023]","author":"Atmar","year":"2023","journal-title":"J Infect Dis"},{"key":"2024031919121902300_jiae085-B28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/v11050432","article-title":"The antigenic topology of norovirus as defined by B and T cell epitope mapping: implications for universal vaccines and therapeutics","volume":"11","author":"van Loben Sels","year":"2019","journal-title":"Viruses"},{"key":"2024031919121902300_jiae085-B29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2018.08.039","article-title":"Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses","volume":"155","author":"Alvarado","year":"2018","journal-title":"Gastroenterology"},{"key":"2024031919121902300_jiae085-B30","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1038\/s41467-021-24649-w","article-title":"Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses","volume":"12","author":"Alvarado","year":"2021","journal-title":"Nat Commun"},{"key":"2024031919121902300_jiae085-B31","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.immuni.2019.05.007","article-title":"Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination","volume":"50","author":"Lindesmith","year":"2019","journal-title":"Immunity"},{"key":"2024031919121902300_jiae085-B32","doi-asserted-by":"crossref","first-page":"E5830","DOI":"10.1073\/pnas.1609990113","article-title":"Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody","volume":"113","author":"Shanker","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024031919121902300_jiae085-B33","doi-asserted-by":"crossref","first-page":"1040836","DOI":"10.3389\/fimmu.2022.1040836","article-title":"Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein","volume":"13","author":"Ford-Siltz","year":"2022","journal-title":"Front Immunol"},{"key":"2024031919121902300_jiae085-B34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/oxfordjournals.aje.a121548","article-title":"Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology","volume":"98","author":"Buscho","year":"1973","journal-title":"Am J Epidemiol"},{"key":"2024031919121902300_jiae085-B35","doi-asserted-by":"crossref","first-page":"ofx236","DOI":"10.1093\/ofid\/ofx236","article-title":"Sequential gastroenteritis outbreaks in a single year caused by norovirus genotypes GII.2 and GII.6 in an institutional setting","volume":"4","author":"Karangwa","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024031919121902300_jiae085-B36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015874118","article-title":"Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses","volume":"118","author":"Kendra","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024031919121902300_jiae085-B37","doi-asserted-by":"crossref","first-page":"e02202","DOI":"10.1128\/mBio.02202-19","article-title":"Population genomics of GII.4 noroviruses reveal complex diversification and new antigenic sites involved in the emergence of pandemic strains","volume":"10","author":"Tohma","year":"2019","journal-title":"mBio"},{"key":"2024031919121902300_jiae085-B38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jpids\/piac063","article-title":"Preexisting heterotypic ligand-blocking antibody does not protect against genogroup II norovirus episodes in young children","volume":"11","author":"Becker-Dreps","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2024031919121902300_jiae085-B39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid2006.131627","article-title":"Sequential gastroenteritis episodes caused by 2 norovirus genotypes","volume":"20","author":"Parra","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024031919121902300_jiae085-B40","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01861-22","article-title":"Immune imprinting drives human norovirus potential for global spread","volume":"13","author":"Lindesmith","year":"2022","journal-title":"mBio"},{"key":"2024031919121902300_jiae085-B41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/vim.2012.0082","article-title":"Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype","volume":"26","author":"Tamminen","year":"2013","journal-title":"Viral Immunol"},{"key":"2024031919121902300_jiae085-B42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41586-023-05715-3","article-title":"Molecular fate-mapping of serum antibody responses to repeat immunization","volume":"615","author":"Schiepers","year":"2023","journal-title":"Nature"},{"key":"2024031919121902300_jiae085-B43","doi-asserted-by":"crossref","first-page":"e2354","DOI":"10.1002\/rmv.2354","article-title":"Global and regional circulation trends of norovirus genotypes and recombinants, 1995\u20132019: a comprehensive review of sequences from public databases","volume":"32","author":"Kendra","year":"2022","journal-title":"Rev Med Virol"},{"key":"2024031919121902300_jiae085-B44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00516-14","article-title":"Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity","volume":"22","author":"Czak\u00f3","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2024031919121902300_jiae085-B45","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3390\/v14092053","article-title":"Norovirus infection in young Nicaraguan children induces durable and genotype-specific antibody immunity","volume":"14","author":"Brewer-Jensen","year":"2022","journal-title":"Viruses"},{"key":"2024031919121902300_jiae085-B46","doi-asserted-by":"crossref","first-page":"e00567","DOI":"10.1128\/JVI.00567-17","article-title":"Human sera collected between 1979 and 2010 possess blocking-antibody titers to pandemic GII.4 noroviruses isolated over three decades","volume":"91","author":"Sharma","year":"2017","journal-title":"J Virol"},{"key":"2024031919121902300_jiae085-B47","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/JVI.06189-11","article-title":"Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity","volume":"86","author":"Debbink","year":"2012","journal-title":"J Virol"},{"key":"2024031919121902300_jiae085-B48","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII.4\u20132002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J Virol"},{"key":"2024031919121902300_jiae085-B49","doi-asserted-by":"crossref","first-page":"e1002921","DOI":"10.1371\/journal.ppat.1002921","article-title":"Norovirus immunity and the great escape","volume":"8","author":"Debbink","year":"2012","journal-title":"PLoS Pathog"},{"key":"2024031919121902300_jiae085-B50","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1016\/j.vaccine.2020.07.069","article-title":"Efficacy of an intramuscular bivalent norovirus GI.1\/GII.4 virus-like particle vaccine candidate in healthy US adults","volume":"38","author":"Sherwood","year":"2020","journal-title":"Vaccine"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae085\/57021014\/jiae085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae085\/57021014\/jiae085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T19:57:23Z","timestamp":1710878243000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiae085\/7612218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae085","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"article-number":"jiae085"}}